Antimicrobial disc (AMD) infection prevention in central venous catheters

Phase 4

Completed

• Conditions: Central-line associated bloodstream infection; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12619000918123
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-01
• Study Completion: 2020-02-03
• Last Update Posted: 12 April 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

(1) Greater than or equal to 18 years old.
(2) Requires a CVC for greater than or equal to 72 hours
(3) Informed, written consent

Exclusion Criteria

(1) Current bloodstream infection (laboratory confirmed within 48 hours of screening)
(2) Concurrent CVC present or anticipated for > 24 hours
(3) Non-English speaking without an interpreter
(4) Previous study enrolment
(5) Known CHG or PHMB allergy
(6) Pre-existing dermatitis/rash/burns at insertion site

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility and safety of the study interventions and protocol, as a composite of: a. Eligibility (>80% of screened patients meeting all inclusion and no exclusion criteria) b. Recruitment (>80% of eligible patients providing informed consent) c. Retention (<5% of recruited patients lost to follow up or withdrawing consent) d. Protocol fidelity (>90% of randomised patients receiving their allocated intervention) e. Missing data (<5% of total data unable to be collected) f. Patient and staff satisfaction with study intervention/s and control (>80% of patients and staff scoring >7 on an 11-point Numerical Rating Scale [on application and removal of intervention and control arm dressings])[At trial completion. ]